Diabetic peripheral neuropathy (DPN) remains undertreated, according to Loretta Vileikyte, MD, PhD (left), who will discuss the psychosocial impact of painful DPN during a symposium beginning at 4:30 p.m. CT on Sunday. Stephanie Eid, PhD, will discuss efforts to develop mechanism-based therapies that impact peripheral neuropathy before irreversible nerve damage occurs.
Up next: Experts will discuss emerging directions in diabetic neuropathy research and treatment
